Načítá se...
Recent advances in post autologous transplantation maintenance therapies in B-cell non-Hodgkin lymphomas
Lymphomas constitute the second most common indication for high dose therapy (HDT) followed by autologous hematopoietic cell transplantation (auto-HCT). The intent of administering HDT in these heterogeneous disorders varies from cure (e.g., in relapsed aggressive lymphomas) to disease control (e.g....
Uloženo v:
| Vydáno v: | World J Transplant |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Baishideng Publishing Group Inc
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4580930/ https://ncbi.nlm.nih.gov/pubmed/26421260 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5500/wjt.v5.i3.81 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|